A detailed history of Keybank National Association transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Keybank National Association holds 21,506 shares of CABA stock, worth $44,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,506
Previous 21,506 -0.0%
Holding current value
$44,732
Previous $160,000 36.88%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$7.22 - $18.82 $40,518 - $105,617
5,612 Added 35.31%
21,506 $160,000
Q1 2024

May 14, 2024

BUY
$16.79 - $25.38 $266,860 - $403,389
15,894 New
15,894 $271,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $60.3M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.